Emmaus Life Sciences, Inc. ( OTCQB : EMMA) , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Ladies and gentlemen, greetings, and welcome to the KORU Medical ...

CHICAGO, IL / ACCESSWIRE / November 12, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a ...

NASDAQ:HROW) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ETCompany ParticipantsJamie Webb - Director, Communications ...

This was a transformative moment for Cosmos, allowing us to strengthen our balance sheet through aggressive ... our ...

FDA approval of MIPLYFFATM and product launch cap third quarter filled with multiple commercial and clinical development milestones Zevra ...

New York City has over 124,000 buildings with lead pipes, city data analyzed by the New York League of Conservation Voters ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Q3 2024 Earnings Call Transcript November 14, 2024 Sensus Healthcare, Inc. beats earnings expectations. Reported EPS is $0.07 ...

The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 ...

Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.

“Children’s Product” does not include the following things: (1) batteries; (2) consumer electronic products; (3) a food or beverage or an additive to a food and beverage regulated by the FDA; or (4) a ...